Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
275 | 43399 | 35.6 | 71% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
275 | 3 | NSAIDS//CYCLOOXYGENASE//CYCLOOXYGENASE 2 | 43399 |
466 | 2 | NSAIDS//NON STEROIDAL ANTI INFLAMMATORY DRUGS//COX 2 INHIBITORS | 15930 |
566 | 2 | EPOXYEICOSATRIENOIC ACIDS//LIPOXYGENASE//LEUKOTRIENES | 14430 |
1311 | 2 | PROSTAGLANDIN D 2//CRTH2//MOL BEHAV BIOL | 8520 |
2305 | 2 | CYCLOOXYGENASE 2//COX 2//CELECOXIB | 4519 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NSAIDS | authKW | 277897 | 3% | 34% | 1178 |
2 | CYCLOOXYGENASE | authKW | 198819 | 2% | 29% | 995 |
3 | CYCLOOXYGENASE 2 | authKW | 196073 | 2% | 28% | 990 |
4 | NON STEROIDAL ANTI INFLAMMATORY DRUGS | authKW | 182255 | 2% | 29% | 892 |
5 | LIPOXYGENASE | authKW | 177826 | 2% | 35% | 728 |
6 | COX 2 | authKW | 177596 | 2% | 28% | 901 |
7 | CELECOXIB | authKW | 173828 | 1% | 42% | 592 |
8 | EPOXYEICOSATRIENOIC ACIDS | authKW | 171857 | 1% | 80% | 306 |
9 | LEUKOTRIENES | authKW | 170644 | 2% | 36% | 671 |
10 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | journal | 141631 | 1% | 34% | 605 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 72649 | 25% | 1% | 11036 |
2 | Biochemistry & Molecular Biology | 15266 | 19% | 1% | 8437 |
3 | Chemistry, Medicinal | 14020 | 6% | 1% | 2622 |
4 | Rheumatology | 8414 | 3% | 1% | 1227 |
5 | Medicine, General & Internal | 6837 | 7% | 1% | 3234 |
6 | Medicine, Research & Experimental | 5466 | 5% | 1% | 2325 |
7 | Cell Biology | 5285 | 8% | 0% | 3339 |
8 | Peripheral Vascular Diseases | 4400 | 4% | 1% | 1612 |
9 | Gastroenterology & Hepatology | 4015 | 4% | 1% | 1614 |
10 | Endocrinology & Metabolism | 3734 | 5% | 0% | 2103 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EXPT THER EUT REPERFUS INJURY | 97049 | 1% | 57% | 245 |
2 | MOL BEHAV BIOL | 41314 | 0% | 48% | 122 |
3 | EICOSANOID | 23015 | 0% | 86% | 38 |
4 | CHEM 2 | 22754 | 0% | 49% | 67 |
5 | PAIN NUFFIELD ANAESTHET | 20136 | 0% | 55% | 52 |
6 | PHYSIOL CHEM 2 | 17252 | 0% | 29% | 84 |
7 | ANESTHESIOL PERIOPERAT PAIN MED | 16578 | 0% | 13% | 188 |
8 | CLAUDE PEPPER | 15417 | 0% | 48% | 46 |
9 | AB HANCOCK JR MEM CANC | 14342 | 0% | 50% | 41 |
10 | MINASE | 14286 | 0% | 29% | 70 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 141631 | 1% | 34% | 605 |
2 | ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH | 137124 | 1% | 50% | 394 |
3 | PROSTAGLANDINS | 92334 | 1% | 30% | 441 |
4 | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 53547 | 1% | 16% | 491 |
5 | PROSTAGLANDINS LEUKOTRIENES AND MEDICINE | 45839 | 1% | 27% | 240 |
6 | EUROPEAN JOURNAL OF RHEUMATOLOGY AND INFLAMMATION | 22653 | 0% | 45% | 72 |
7 | EICOSANOIDS | 14899 | 0% | 42% | 51 |
8 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 13916 | 1% | 7% | 314 |
9 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 9974 | 1% | 3% | 573 |
10 | PROSTAGLANDINS AND MEDICINE | 7960 | 0% | 22% | 51 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NSAIDS | 277897 | 3% | 34% | 1178 | Search NSAIDS | Search NSAIDS |
2 | CYCLOOXYGENASE | 198819 | 2% | 29% | 995 | Search CYCLOOXYGENASE | Search CYCLOOXYGENASE |
3 | CYCLOOXYGENASE 2 | 196073 | 2% | 28% | 990 | Search CYCLOOXYGENASE+2 | Search CYCLOOXYGENASE+2 |
4 | NON STEROIDAL ANTI INFLAMMATORY DRUGS | 182255 | 2% | 29% | 892 | Search NON+STEROIDAL+ANTI+INFLAMMATORY+DRUGS | Search NON+STEROIDAL+ANTI+INFLAMMATORY+DRUGS |
5 | LIPOXYGENASE | 177826 | 2% | 35% | 728 | Search LIPOXYGENASE | Search LIPOXYGENASE |
6 | COX 2 | 177596 | 2% | 28% | 901 | Search COX+2 | Search COX+2 |
7 | CELECOXIB | 173828 | 1% | 42% | 592 | Search CELECOXIB | Search CELECOXIB |
8 | EPOXYEICOSATRIENOIC ACIDS | 171857 | 1% | 80% | 306 | Search EPOXYEICOSATRIENOIC+ACIDS | Search EPOXYEICOSATRIENOIC+ACIDS |
9 | LEUKOTRIENES | 170644 | 2% | 36% | 671 | Search LEUKOTRIENES | Search LEUKOTRIENES |
10 | COX 2 INHIBITORS | 133784 | 1% | 55% | 347 | Search COX+2+INHIBITORS | Search COX+2+INHIBITORS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HAEGGSTROM, JZ , FUNK, CD , (2011) LIPOXYGENASE AND LEUKOTRIENE PATHWAYS: BIOCHEMISTRY, BIOLOGY, AND ROLES IN DISEASE.CHEMICAL REVIEWS. VOL. 111. ISSUE 10. P. 5866 -5898 | 359 | 81% | 196 |
2 | WOODWARD, DF , JONES, RL , NARUMIYA, S , (2011) INTERNATIONAL UNION OF BASIC AND CLINICAL PHARMACOLOGY. LXXXIII: CLASSIFICATION OF PROSTANOID RECEPTORS, UPDATING 15 YEARS OF PROGRESS.PHARMACOLOGICAL REVIEWS. VOL. 63. ISSUE 3. P. 471 -538 | 529 | 59% | 146 |
3 | NAKAMURA, M , SHIMIZU, T , (2011) LEUKOTRIENE RECEPTORS.CHEMICAL REVIEWS. VOL. 111. ISSUE 10. P. 6231 -6298 | 554 | 71% | 23 |
4 | CAPRA, V , BACK, M , BARBIERI, SS , CAMERA, M , TREMOLI, E , ROVATI, GE , (2013) EICOSANOIDS AND THEIR DRUGS IN CARDIOVASCULAR DISEASES: FOCUS ON ATHEROSCLEROSIS AND STROKE.MEDICINAL RESEARCH REVIEWS. VOL. 33. ISSUE 2. P. 364-438 | 446 | 69% | 18 |
5 | IMIG, JD , (2012) EPOXIDES AND SOLUBLE EPOXIDE HYDROLASE IN CARDIOVASCULAR PHYSIOLOGY.PHYSIOLOGICAL REVIEWS. VOL. 92. ISSUE 1. P. 101-130 | 278 | 86% | 114 |
6 | BACK, M , DAHLEN, SE , DRAZEN, JM , EVANS, JF , SERHAN, CN , SHIMIZU, T , YOKOMIZO, T , ROVATI, GE , (2011) INTERNATIONAL UNION OF BASIC AND CLINICAL PHARMACOLOGY. LXXXIV: LEUKOTRIENE RECEPTOR NOMENCLATURE, DISTRIBUTION, AND PATHOPHYSIOLOGICAL FUNCTIONS.PHARMACOLOGICAL REVIEWS. VOL. 63. ISSUE 3. P. 539-584 | 427 | 67% | 37 |
7 | KUHN, H , BANTHIYA, S , VAN LEYEN, K , (2015) MAMMALIAN LIPOXYGENASES AND THEIR BIOLOGICAL RELEVANCE.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS. VOL. 1851. ISSUE 4. P. 308 -330 | 270 | 69% | 39 |
8 | SIMMONS, DL , BOTTING, RM , HLA, T , (2004) CYCLOOXYGENASE ISOZYMES: THE BIOLOGY OF PROSTAGLANDIN SYNTHESIS AND INHIBITION.PHARMACOLOGICAL REVIEWS. VOL. 56. ISSUE 3. P. 387-437 | 293 | 66% | 742 |
9 | ROMAN, RJ , (2002) P-450 METABOLITES OF ARACHIDONIC ACID IN THE CONTROL OF CARDIOVASCULAR FUNCTION.PHYSIOLOGICAL REVIEWS. VOL. 82. ISSUE 1. P. 131 -185 | 294 | 61% | 792 |
10 | BASIL, MC , LEVY, BD , (2016) SPECIALIZED PRO-RESOLVING MEDIATORS: ENDOGENOUS REGULATORS OF INFECTION AND INFLAMMATION.NATURE REVIEWS IMMUNOLOGY. VOL. 16. ISSUE 1. P. 51 -67 | 148 | 77% | 19 |
Classes with closest relation at Level 3 |